{"gene":"CASP9","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":1996,"finding":"ICE-LAP6 (CASP9) is proteolytically processed and activated by granzyme B, a cytotoxic T cell protease. Once activated, ICE-LAP6 cleaves the death substrate poly(ADP-ribose) polymerase (PARP) into signature apoptotic fragments. ICE-LAP6 contains an active site QACGG pentapeptide (rather than QACRG shared by other family members) and overexpression induces apoptosis.","method":"In vitro cleavage assay with granzyme B, overexpression in MCF7 cells, PARP cleavage assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic assay demonstrating granzyme B processing and downstream substrate cleavage, replicated across two independent 1996 papers","pmids":["8663294"],"is_preprint":false},{"year":1996,"finding":"Pro-Mch6 (pro-CASP9) is a substrate for mature CPP32 (caspase-3), which processes it preferentially at Asp330 to generate 37 kDa and 10 kDa subunits. Granzyme B can also process pro-Mch6 but at a site N-terminal to that cleaved by CPP32. This established a protease cascade: granzyme B → CPP32 → Mch6, placing CASP9 downstream of CPP32 in granzyme B-mediated apoptosis.","method":"In vitro cleavage assay, site-directed mutagenesis at Asp330, SDS-PAGE analysis of processing products","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis identifying precise cleavage site, supported by two independent 1996 studies","pmids":["8900201"],"is_preprint":false},{"year":2007,"finding":"Upon UV irradiation, histone H1.2 forms a protein complex with APAF-1, CASP9, and cytochrome c (CYT c). In cell-free systems, histone H1.2 triggers activation of CASP-3 and CASP-7 via APAF-1 and CASP-9, establishing histone H1.2 as a positive regulator of apoptosome formation.","method":"Affinity labeling, mass spectrometry, cell-free caspase activation assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-free reconstitution plus affinity pulldown/MS identifying the complex, single lab with two orthogonal methods","pmids":["17618626"],"is_preprint":false},{"year":2019,"finding":"CASP9 (caspase 9) has a non-apoptotic function required for autophagosome maturation. In CASP9 knockout cells, phagophore initiation and elongation are normal but membrane sealing and autophagosome maturation are impaired, ATG3 accumulates in inactive form, and lipidation of Atg8-family members (especially GABARAPL1) is decreased. CASP9 also maintains mitochondrial homeostasis (membrane potential, ROS production, fusion-fission protein levels). Exogenous H2O2 can rescue ATG3 levels and autophagy flux but not mitochondrial defects, indicating separate CASP9-dependent mitochondrial regulatory function.","method":"CASP9 knockout (CRISPR), ectopic re-expression rescue, pharmacological inhibition, super-resolution microscopy, western blot for ATG3 and LC3 lipidation, mitochondrial membrane potential assay","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined molecular phenotype, rescue experiments, multiple orthogonal readouts in single rigorous study","pmids":["31818185"],"is_preprint":false},{"year":2020,"finding":"CASP9 localizes to endosomal membranes and facilitates retrograde transport of IGF2R/CI-MPR from endosomes to the trans-Golgi network via a non-apoptotic, non-catalytic mechanism. CASP9-deficient cells show missorted CTSD and other acid hydrolases, late endosome accumulation, and reduced lysosomal protein degradation. Rescue by a non-catalytic CASP9 mutant confirms the effect is independent of proteolytic activity. CASP9 interacts with retromer components VPS35, SNX1-SNX5 and SNX2-SNX6 dimers, as well as HGS/HRS/ESCRT-0 and clathrin heavy chain (CLTC).","method":"CASP9 KO and knockdown, co-immunoprecipitation of endosomal transport complexes, rescue with non-catalytic mutant, subcellular fractionation, immunofluorescence, IGF2R degradation assay","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO with defined molecular phenotype, catalytic mutant rescue, reciprocal Co-IP identifying binding partners, multiple orthogonal methods in single rigorous study","pmids":["32397873"],"is_preprint":false},{"year":2018,"finding":"In KRAS-mutant NSCLC cells surviving HSP90 inhibition, elevated CASP9 prodomain expression at late endosomal/pre-lysosomal membranes serves as a cell survival mechanism that does not involve CASP9 apoptotic activity and is largely ATG7-independent.","method":"HSP90 inhibitor treatment, CASP9 expression analysis, subcellular localization by immunofluorescence, functional cell survival assays","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, localization linked to functional consequence, but mechanistic details limited in abstract","pmids":["29561705"],"is_preprint":false},{"year":2018,"finding":"NTD-specific missense variant p.Y251C in CASP9 attenuates apoptosis by reducing CASP9 protein expression and decreasing intrinsic apoptosis pathway activity (loss-of-function). A recurrent p.R191G variant does not affect intrinsic apoptosis under normal conditions but completely inhibits apoptosis induced by low folic acid medium, demonstrating gene-environment interaction.","method":"High-throughput sequencing of NTD cases and controls, functional apoptosis assays in transiently transfected neuroepithelial cells and HEK293T cells, caspase activity assays under complete and low-FA conditions","journal":"CNS neuroscience & therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mutagenesis in cell-based assays with defined apoptotic readouts, single lab with two orthogonal methods","pmids":["29365368"],"is_preprint":false},{"year":2020,"finding":"NF-κB directly binds to the CASP9 promoter and upregulates CASP9 expression in TNFα-treated HeLa and HepG2 cells. NF-κB simultaneously downregulates miR-1276, which itself represses CASP9, forming a coherent feed-forward loop that amplifies CASP9 upregulation. CASP9 is subsequently activated and mediates TNFα-promoted apoptosis induced by doxorubicin; a CASP9 activation inhibitor significantly represses this pro-apoptotic effect.","method":"ChIP (NF-κB binding to CASP9 and miR-1276 promoters), luciferase reporter, western blot for CASP9 activation, pharmacological inhibition of CASP9","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays plus functional inhibition, single lab with multiple orthogonal methods","pmids":["32225068"],"is_preprint":false},{"year":2014,"finding":"CASP9-deficient MEFs (casp9-/-) show prolonged activation of the unfolded protein response (UPR) and autophagy compared to casp9+/+ MEFs under ER stress, which display only transient UPR/autophagy activation. Casp9-/- MEFs are resistant to ER stress-induced cell death, but prolonged exposure leads to activation of a non-canonical, caspase-mediated mode of cell death.","method":"Comparative analysis of casp9+/+ vs casp9-/- mouse embryonic fibroblasts under ER stress, UPR markers, autophagy markers, cell viability assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic KO MEF comparison with multiple pathway readouts, single lab","pmids":["25086361"],"is_preprint":false}],"current_model":"CASP9 (caspase-9) is an initiator caspase that is activated by granzyme B cleavage at Asp330 (or by CPP32/caspase-3 in a downstream cascade) to become an active cysteine protease that cleaves PARP and propagates the intrinsic apoptotic cascade; it is recruited into the apoptosome with APAF-1 and cytochrome c (positively regulated by histone H1.2 upon DNA damage), is transcriptionally upregulated by NF-κB via a miR-1276 feed-forward loop; and beyond apoptosis, CASP9 performs non-apoptotic functions including maintenance of mitochondrial homeostasis required for autophagosome maturation/closure via the Atg8 conjugation system, and non-catalytic facilitation of IGF2R retrograde endosome-to-TGN transport through interactions with retromer (VPS35) and SNX-BAR complexes."},"narrative":{"mechanistic_narrative":"CASP9 (caspase-9) is an initiator cysteine protease of the intrinsic apoptotic pathway that, once proteolytically activated, cleaves downstream death substrates including poly(ADP-ribose) polymerase (PARP) [PMID:8663294]. It is processed and activated by the cytotoxic lymphocyte protease granzyme B and operates within a protease cascade in which mature caspase-3/CPP32 cleaves pro-CASP9 preferentially at Asp330 to liberate its catalytic subunits, placing CASP9 downstream of caspase-3 in granzyme B-mediated death [PMID:8663294, PMID:8900201]. Apoptosome-dependent activation of CASP9 requires assembly with APAF-1 and cytochrome c, a step positively regulated by histone H1.2 following UV-induced DNA damage [PMID:17618626]. CASP9 expression is transcriptionally amplified by NF-κB, which directly binds the CASP9 promoter while repressing the CASP9-targeting miR-1276 in a coherent feed-forward loop that potentiates TNFα/doxorubicin-induced apoptosis [PMID:32225068]. Beyond apoptosis, CASP9 has distinct non-apoptotic roles: it maintains mitochondrial homeostasis and is required for autophagosome membrane sealing and maturation through proper ATG3 function and Atg8-family (GABARAPL1) lipidation [PMID:31818185], and it acts non-catalytically at endosomal membranes to facilitate retrograde IGF2R/CI-MPR transport from endosomes to the trans-Golgi network via interactions with the retromer subunit VPS35, SNX-BAR dimers (SNX1-SNX5, SNX2-SNX6), ESCRT-0 (HGS), and clathrin heavy chain [PMID:32397873]. Loss-of-function CASP9 variants that attenuate intrinsic apoptosis are associated with neural tube defects, including a folate-dependent gene-environment interaction [PMID:29365368].","teleology":[{"year":1996,"claim":"Established CASP9 as a death protease by showing it is activated by granzyme B and cleaves a canonical apoptotic substrate, defining its place in cytotoxic-lymphocyte-triggered apoptosis.","evidence":"In vitro granzyme B cleavage assay, overexpression in MCF7 cells, and PARP cleavage readout","pmids":["8663294"],"confidence":"High","gaps":["Did not resolve the physiological upstream activator versus granzyme B","Apoptosome requirement for activation not yet defined","No structural basis for the divergent QACGG active site"]},{"year":1996,"claim":"Defined the precise activating cleavage site (Asp330) and ordered the cascade, placing CASP9 downstream of caspase-3/CPP32 in granzyme B-mediated apoptosis.","evidence":"In vitro cleavage with site-directed Asp330 mutagenesis and SDS-PAGE analysis of subunit products","pmids":["8900201"],"confidence":"High","gaps":["Hierarchy between CASP9 and caspase-3 in other death stimuli not addressed","In-cell relevance of each cleavage site not quantified"]},{"year":2007,"claim":"Identified a DNA-damage-linked positive regulator of apoptosome activation, showing histone H1.2 promotes APAF-1/CASP9/cytochrome c assembly and downstream caspase-3/7 activation.","evidence":"Affinity labeling, mass spectrometry, and cell-free caspase activation assay after UV irradiation","pmids":["17618626"],"confidence":"Medium","gaps":["Stoichiometry and direct binding interface within the apoptosome unstructured","In vivo contribution of H1.2 to apoptosis not established","Single-lab finding without independent replication in the corpus"]},{"year":2014,"claim":"Revealed a function for CASP9 in restraining ER-stress responses, where its loss prolongs UPR and autophagy and confers resistance to ER-stress-induced death.","evidence":"Comparison of isogenic casp9+/+ and casp9-/- MEFs under ER stress with UPR, autophagy, and viability readouts","pmids":["25086361"],"confidence":"Medium","gaps":["Molecular mechanism linking CASP9 to UPR resolution unknown","Whether catalytic activity is required not tested","Nature of the non-canonical death mode undefined"]},{"year":2018,"claim":"Connected CASP9 to human disease by showing loss-of-function variants attenuate intrinsic apoptosis, including a folate-dependent gene-environment interaction relevant to neural tube defects.","evidence":"Sequencing of NTD cohorts plus functional apoptosis/caspase assays in neuroepithelial and HEK293T cells under complete and low-folate conditions","pmids":["29365368"],"confidence":"Medium","gaps":["Causality in NTD pathogenesis not established beyond cell-based assays","Mechanism of the R191G folate-conditional effect unknown"]},{"year":2018,"claim":"Showed a pro-survival, non-apoptotic role for the CASP9 prodomain at late endosomal/pre-lysosomal membranes in drug-tolerant KRAS-mutant cancer cells.","evidence":"HSP90 inhibitor treatment, prodomain expression analysis, immunofluorescence localization, and cell survival assays","pmids":["29561705"],"confidence":"Medium","gaps":["Mechanistic basis of prodomain-driven survival not defined","ATG7-independence only partially characterized","Limited mechanistic detail available"]},{"year":2019,"claim":"Established a non-apoptotic requirement for CASP9 in autophagosome maturation and mitochondrial homeostasis, separating its role in membrane sealing/ATG3-Atg8 lipidation from its mitochondrial regulatory function.","evidence":"CRISPR knockout with re-expression rescue, super-resolution microscopy, ATG3/LC3 lipidation blots, and mitochondrial membrane potential assays with H2O2 rescue","pmids":["31818185"],"confidence":"High","gaps":["Whether the maturation role requires catalytic activity not fully resolved here","Direct molecular target of CASP9 in ATG3 activation unidentified","Mechanism coupling mitochondrial ROS to ATG3 stability unclear"]},{"year":2020,"claim":"Defined a catalytically independent scaffolding role for CASP9 in endosome-to-TGN retrograde transport, with rescue by a non-catalytic mutant confirming proteolysis-independent function.","evidence":"CASP9 KO/knockdown, reciprocal co-immunoprecipitation of retromer/SNX-BAR/ESCRT-0/clathrin partners, non-catalytic mutant rescue, fractionation, and IGF2R degradation assays","pmids":["32397873"],"confidence":"High","gaps":["Direct versus indirect nature of each partner interaction not fully dissected","Structural basis of endosomal membrane recruitment unknown"]},{"year":2020,"claim":"Mapped transcriptional control of CASP9 by showing NF-κB directly activates the promoter while repressing miR-1276 in a feed-forward loop that amplifies CASP9-dependent apoptosis.","evidence":"ChIP and luciferase reporter assays plus CASP9 activation blots and pharmacological CASP9 inhibition in TNFα/doxorubicin-treated HeLa and HepG2 cells","pmids":["32225068"],"confidence":"Medium","gaps":["Generality of the loop across cell types/stimuli untested","Quantitative contribution of miR-1276 versus direct activation unresolved"]},{"year":null,"claim":"How CASP9 switches between its catalytic apoptotic role and its non-catalytic membrane-trafficking and autophagy functions, and what governs its differential localization, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model distinguishing apoptotic versus scaffolding conformations","Signals directing CASP9 to endosomal versus mitochondrial/apoptosome pools unknown","Direct molecular substrates/effectors in autophagy maturation unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4,5]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[3]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1,2,7]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[3]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[4]}],"complexes":["apoptosome (APAF-1/cytochrome c/CASP9)"],"partners":["APAF1","CYCS","HIST1H1C","VPS35","SNX1","SNX5","HGS","CLTC"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P55211","full_name":"Caspase-9","aliases":["Apoptotic protease Mch-6","Apoptotic protease-activating factor 3","APAF-3","ICE-like apoptotic protease 6","ICE-LAP6"],"length_aa":416,"mass_kda":46.3,"function":"Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates effector caspases caspase-3 (CASP3) or caspase-7 (CASP7). Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758105, PubMed:36758106) Lacks activity is an dominant-negative inhibitor of caspase-9","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P55211/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CASP9","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CASP9","total_profiled":1310},"omim":[{"mim_id":"621072","title":"BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 8; BIRC8","url":"https://www.omim.org/entry/621072"},{"mim_id":"620701","title":"TETRATRICOPEPTIDE REPEAT DOMAIN 36; TTC36","url":"https://www.omim.org/entry/620701"},{"mim_id":"619894","title":"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 15; ABHD15","url":"https://www.omim.org/entry/619894"},{"mim_id":"618997","title":"CYTIDINE AND DEOXYCYTIDYLATE DEAMINASE DOMAIN-CONTAINING PROTEIN 1; CDADC1","url":"https://www.omim.org/entry/618997"},{"mim_id":"617163","title":"RING FINGER PROTEIN 186; RNF186","url":"https://www.omim.org/entry/617163"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CASP9"},"hgnc":{"alias_symbol":["MCH6","ICE-LAP6","APAF-3","PPP1R56"],"prev_symbol":[]},"alphafold":{"accession":"P55211","domains":[{"cath_id":"1.10.533.10","chopping":"4-95","consensus_level":"high","plddt":89.008,"start":4,"end":95},{"cath_id":"3.40.50.1460","chopping":"153-295_314-322_336-412","consensus_level":"high","plddt":91.7376,"start":153,"end":412}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P55211","model_url":"https://alphafold.ebi.ac.uk/files/AF-P55211-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P55211-F1-predicted_aligned_error_v6.png","plddt_mean":80.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CASP9","jax_strain_url":"https://www.jax.org/strain/search?query=CASP9"},"sequence":{"accession":"P55211","fasta_url":"https://rest.uniprot.org/uniprotkb/P55211.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P55211/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P55211"}},"corpus_meta":[{"pmid":"8663294","id":"PMC_8663294","title":"ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663294","citation_count":284,"is_preprint":false},{"pmid":"8900201","id":"PMC_8900201","title":"The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8900201","citation_count":269,"is_preprint":false},{"pmid":"22002823","id":"PMC_22002823","title":"Assessment of template based protein structure predictions in CASP9.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/22002823","citation_count":135,"is_preprint":false},{"pmid":"22069036","id":"PMC_22069036","title":"Automated protein structure modeling in CASP9 by I-TASSER pipeline combined with QUARK-based ab initio folding and FG-MD-based structure refinement.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/22069036","citation_count":118,"is_preprint":false},{"pmid":"18086147","id":"PMC_18086147","title":"Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes.","date":"2007","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/18086147","citation_count":103,"is_preprint":false},{"pmid":"22069034","id":"PMC_22069034","title":"Assessment of protein structure refinement in CASP9.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/22069034","citation_count":80,"is_preprint":false},{"pmid":"21997521","id":"PMC_21997521","title":"CASP9 assessment of free modeling target predictions.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/21997521","citation_count":75,"is_preprint":false},{"pmid":"31818185","id":"PMC_31818185","title":"CASP9 (caspase 9) is essential for autophagosome maturation through regulation of mitochondrial homeostasis.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31818185","citation_count":68,"is_preprint":false},{"pmid":"21997462","id":"PMC_21997462","title":"Evaluation of model quality predictions in CASP9.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/21997462","citation_count":65,"is_preprint":false},{"pmid":"21997778","id":"PMC_21997778","title":"CASP9 target classification.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/21997778","citation_count":57,"is_preprint":false},{"pmid":"35522909","id":"PMC_35522909","title":"Exosome-transmitted miR-769-5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53.","date":"2022","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35522909","citation_count":57,"is_preprint":false},{"pmid":"28084318","id":"PMC_28084318","title":"Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer.","date":"2017","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28084318","citation_count":52,"is_preprint":false},{"pmid":"11870543","id":"PMC_11870543","title":"Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.","date":"2002","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11870543","citation_count":34,"is_preprint":false},{"pmid":"29561705","id":"PMC_29561705","title":"HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLC.","date":"2018","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/29561705","citation_count":32,"is_preprint":false},{"pmid":"21763329","id":"PMC_21763329","title":"Activity of selenium on cell proliferation, cytotoxicity, and apoptosis and on the expression of CASP9, BCL-XL and APC in intestinal adenocarcinoma cells.","date":"2011","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/21763329","citation_count":29,"is_preprint":false},{"pmid":"23725396","id":"PMC_23725396","title":"Analysis of association between IL-1β, CASP-9, and GDF5 variants and low-back pain in Chinese male soldier: clinical article.","date":"2013","source":"Journal of neurosurgery. Spine","url":"https://pubmed.ncbi.nlm.nih.gov/23725396","citation_count":29,"is_preprint":false},{"pmid":"17618626","id":"PMC_17618626","title":"Proapoptotic histone H1.2 induces CASP-3 and -7 activation by forming a protein complex with CYT c, APAF-1 and CASP-9.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17618626","citation_count":27,"is_preprint":false},{"pmid":"21994223","id":"PMC_21994223","title":"An automatic method for CASP9 free modeling structure prediction assessment.","date":"2011","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21994223","citation_count":20,"is_preprint":false},{"pmid":"23424205","id":"PMC_23424205","title":"Effects of β-glucan extracted from Agaricus blazei on the expression of ERCC5, CASP9, and CYP1A1 genes and metabolic profile in HepG2 cells.","date":"2013","source":"Human & experimental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/23424205","citation_count":19,"is_preprint":false},{"pmid":"32397873","id":"PMC_32397873","title":"Involvement of CASP9 (caspase 9) in IGF2R/CI-MPR endosomal transport.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/32397873","citation_count":18,"is_preprint":false},{"pmid":"22974165","id":"PMC_22974165","title":"Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.","date":"2012","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22974165","citation_count":18,"is_preprint":false},{"pmid":"32225068","id":"PMC_32225068","title":"Upregulation of CASP9 through NF-κB and Its Target MiR-1276 Contributed to TNFα-promoted Apoptosis of Cancer Cells Induced by Doxorubicin.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32225068","citation_count":18,"is_preprint":false},{"pmid":"23645041","id":"PMC_23645041","title":"Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.","date":"2013","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23645041","citation_count":17,"is_preprint":false},{"pmid":"22020785","id":"PMC_22020785","title":"Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure prediction.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/22020785","citation_count":17,"is_preprint":false},{"pmid":"32017818","id":"PMC_32017818","title":"Analysis of the expression of BAX, BCL2, BIRC6, CASP3, CASP9 apoptosis genes during the first episode of schizophrenia.","date":"2019","source":"Psychiatria polska","url":"https://pubmed.ncbi.nlm.nih.gov/32017818","citation_count":16,"is_preprint":false},{"pmid":"27984487","id":"PMC_27984487","title":"Genetic Susceptibility in Acute Pancreatitis: Genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 Gene Variants.","date":"2017","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/27984487","citation_count":14,"is_preprint":false},{"pmid":"33935122","id":"PMC_33935122","title":"Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis.","date":"2021","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33935122","citation_count":13,"is_preprint":false},{"pmid":"11677110","id":"PMC_11677110","title":"The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastoma.","date":"2001","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/11677110","citation_count":13,"is_preprint":false},{"pmid":"19359048","id":"PMC_19359048","title":"CASP-9: A susceptibility locus for multiple sclerosis in Italy.","date":"2009","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/19359048","citation_count":13,"is_preprint":false},{"pmid":"34463927","id":"PMC_34463927","title":"Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.","date":"2021","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34463927","citation_count":12,"is_preprint":false},{"pmid":"27935156","id":"PMC_27935156","title":"CASP9 germline mutation in a family with multiple brain tumors.","date":"2017","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/27935156","citation_count":12,"is_preprint":false},{"pmid":"31830572","id":"PMC_31830572","title":"Immune genes, IL1β and Casp9, show sexual dimorphic methylation patterns in zebrafish gonads.","date":"2019","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31830572","citation_count":12,"is_preprint":false},{"pmid":"28686330","id":"PMC_28686330","title":"GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation.","date":"2017","source":"Basic & clinical pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28686330","citation_count":11,"is_preprint":false},{"pmid":"34232553","id":"PMC_34232553","title":"Long non-coding RNA LINC00607 silencing exerts antioncogenic effects on thyroid cancer through the CASP9 Promoter methylation.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34232553","citation_count":11,"is_preprint":false},{"pmid":"17285546","id":"PMC_17285546","title":"[A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].","date":"2007","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17285546","citation_count":11,"is_preprint":false},{"pmid":"29365368","id":"PMC_29365368","title":"Genetic screening and functional analysis of CASP9 mutations in a Chinese cohort with neural tube defects.","date":"2018","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29365368","citation_count":10,"is_preprint":false},{"pmid":"28298075","id":"PMC_28298075","title":"Inducing cell proliferative prevention in human acute promyelocytic leukemia by miR-182 inhibition through modulation of CASP9 expression.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28298075","citation_count":10,"is_preprint":false},{"pmid":"24427328","id":"PMC_24427328","title":"KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9.","date":"2013","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24427328","citation_count":10,"is_preprint":false},{"pmid":"28503451","id":"PMC_28503451","title":"Association Between a Polymorphism in CASP3 and CASP9 Genes and Ischemic Stroke.","date":"2017","source":"Annals of rehabilitation medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28503451","citation_count":8,"is_preprint":false},{"pmid":"23479167","id":"PMC_23479167","title":"CASP-9 gene functional polymorphisms and cancer risk: a large-scale association study plus meta-analysis.","date":"2013","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/23479167","citation_count":8,"is_preprint":false},{"pmid":"30043639","id":"PMC_30043639","title":"FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.","date":"2018","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/30043639","citation_count":7,"is_preprint":false},{"pmid":"11393657","id":"PMC_11393657","title":"Two novel single-nucleotide polymorphisms of the Caspase-9 (CASP9) gene in the Japanese population.","date":"2001","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11393657","citation_count":7,"is_preprint":false},{"pmid":"23303631","id":"PMC_23303631","title":"Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population.","date":"2013","source":"Journal of Zhejiang University. Science. B","url":"https://pubmed.ncbi.nlm.nih.gov/23303631","citation_count":6,"is_preprint":false},{"pmid":"22809379","id":"PMC_22809379","title":"Recursive protein modeling: a divide and conquer strategy for Protein Structure Prediction and its case study in CASP9.","date":"2012","source":"Journal of bioinformatics and computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/22809379","citation_count":6,"is_preprint":false},{"pmid":"30903678","id":"PMC_30903678","title":"CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.","date":"2019","source":"Head & neck","url":"https://pubmed.ncbi.nlm.nih.gov/30903678","citation_count":5,"is_preprint":false},{"pmid":"21644232","id":"PMC_21644232","title":"[Association of CASP3 and CASP9 polymorphisms with genetic susceptibility to stomach cancer].","date":"2011","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21644232","citation_count":5,"is_preprint":false},{"pmid":"23251262","id":"PMC_23251262","title":"Role of the CASP-9 Ex5+32 G>A polymorphism in susceptibility to cancer: A meta-analysis.","date":"2012","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23251262","citation_count":4,"is_preprint":false},{"pmid":"40643716","id":"PMC_40643716","title":"USP6NL knockdown suppresses colorectal cancer progression by inducing CASP9-Mediated apoptosis and disrupting FOXC2/SNAI1-Driven EMT and angiogenesis.","date":"2025","source":"Functional & integrative genomics","url":"https://pubmed.ncbi.nlm.nih.gov/40643716","citation_count":3,"is_preprint":false},{"pmid":"27951722","id":"PMC_27951722","title":"[Clinical and Functional Importance of Selected CASP8 and CASP9 Polymorphisms in Breast Carcinoma].","date":"2016","source":"Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti","url":"https://pubmed.ncbi.nlm.nih.gov/27951722","citation_count":3,"is_preprint":false},{"pmid":"40010561","id":"PMC_40010561","title":"Novel strategy for hair regeneration: Exosomes and collagenous sequences of human a1(XVII) chain enhance hair follicle stem cell activity by regulating the hsa-novel-238a-CASP9 axis.","date":"2025","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/40010561","citation_count":3,"is_preprint":false},{"pmid":"22166115","id":"PMC_22166115","title":"Unsupervised Integration of Multiple Protein Disorder Predictors: The Method and Evaluation on CASP7, CASP8 and CASP9 Data.","date":"2011","source":"Proteome science","url":"https://pubmed.ncbi.nlm.nih.gov/22166115","citation_count":3,"is_preprint":false},{"pmid":"37658984","id":"PMC_37658984","title":"Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patients.","date":"2023","source":"Journal of applied genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37658984","citation_count":2,"is_preprint":false},{"pmid":"25086361","id":"PMC_25086361","title":"ER stress responses in the absence of apoptosome: a comparative study in CASP9 proficient vs deficient mouse embryonic fibroblasts.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25086361","citation_count":2,"is_preprint":false},{"pmid":"32816327","id":"PMC_32816327","title":"Influence of CASP9 c.-1339A>G and CASP3 c.-1191A>G variants in outcome of patients with head and neck squamous cell carcinoma.","date":"2020","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32816327","citation_count":1,"is_preprint":false},{"pmid":"40753129","id":"PMC_40753129","title":"Antineoplastic potential of Kushneria avicenniae pigments via modulation of the BAX/BCL-2 axis and CASP-9 pathway in inducing G2/M arrest and apoptosis in liver and breast cancer.","date":"2025","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/40753129","citation_count":1,"is_preprint":false},{"pmid":"27327132","id":"PMC_27327132","title":"Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting target.","date":"2017","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27327132","citation_count":0,"is_preprint":false},{"pmid":"40094535","id":"PMC_40094535","title":"Transcriptome analysis and molecular docking reveal the activation of FOXO4, TNFSF15 and CASP9 in HeLa cells treated with DCM fraction from Clinacanthus nutans (C. nutans).","date":"2025","source":"Journal of Asian natural products research","url":"https://pubmed.ncbi.nlm.nih.gov/40094535","citation_count":0,"is_preprint":false},{"pmid":"41320686","id":"PMC_41320686","title":"Overexpression of CASP-3, CASP-8, CASP-9 and P53 in HT-29 Cancer Cells after Co-Treatment of New Strain of Lactobacillus Crispatus Extract and Doxorobixin and Complementary Docking Study.","date":"2025","source":"Current microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/41320686","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.26.656236","title":"Transgenic  <i>Bax</i>  gene efficiently induces lethality in mouse early embryos","date":"2025-05-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.26.656236","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.04.641378","title":"The structural basis of drugs targeting protein-protein interactions uncovered with the protein-ligand interaction profiler PLIP","date":"2025-03-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.04.641378","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.19.24317595","title":"c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer’s disease","date":"2024-11-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.19.24317595","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.29.605666","title":"Effects of two different compounds on seizure suppression using the zebrafish PTZ-seizure model","date":"2024-07-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.29.605666","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34811,"output_tokens":2762,"usd":0.072931,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9921,"output_tokens":3706,"usd":0.071127,"stage2_stop_reason":"end_turn"},"total_usd":0.144058,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"ICE-LAP6 (CASP9) is proteolytically processed and activated by granzyme B, a cytotoxic T cell protease. Once activated, ICE-LAP6 cleaves the death substrate poly(ADP-ribose) polymerase (PARP) into signature apoptotic fragments. ICE-LAP6 contains an active site QACGG pentapeptide (rather than QACRG shared by other family members) and overexpression induces apoptosis.\",\n      \"method\": \"In vitro cleavage assay with granzyme B, overexpression in MCF7 cells, PARP cleavage assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic assay demonstrating granzyme B processing and downstream substrate cleavage, replicated across two independent 1996 papers\",\n      \"pmids\": [\"8663294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Pro-Mch6 (pro-CASP9) is a substrate for mature CPP32 (caspase-3), which processes it preferentially at Asp330 to generate 37 kDa and 10 kDa subunits. Granzyme B can also process pro-Mch6 but at a site N-terminal to that cleaved by CPP32. This established a protease cascade: granzyme B → CPP32 → Mch6, placing CASP9 downstream of CPP32 in granzyme B-mediated apoptosis.\",\n      \"method\": \"In vitro cleavage assay, site-directed mutagenesis at Asp330, SDS-PAGE analysis of processing products\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis identifying precise cleavage site, supported by two independent 1996 studies\",\n      \"pmids\": [\"8900201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Upon UV irradiation, histone H1.2 forms a protein complex with APAF-1, CASP9, and cytochrome c (CYT c). In cell-free systems, histone H1.2 triggers activation of CASP-3 and CASP-7 via APAF-1 and CASP-9, establishing histone H1.2 as a positive regulator of apoptosome formation.\",\n      \"method\": \"Affinity labeling, mass spectrometry, cell-free caspase activation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-free reconstitution plus affinity pulldown/MS identifying the complex, single lab with two orthogonal methods\",\n      \"pmids\": [\"17618626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CASP9 (caspase 9) has a non-apoptotic function required for autophagosome maturation. In CASP9 knockout cells, phagophore initiation and elongation are normal but membrane sealing and autophagosome maturation are impaired, ATG3 accumulates in inactive form, and lipidation of Atg8-family members (especially GABARAPL1) is decreased. CASP9 also maintains mitochondrial homeostasis (membrane potential, ROS production, fusion-fission protein levels). Exogenous H2O2 can rescue ATG3 levels and autophagy flux but not mitochondrial defects, indicating separate CASP9-dependent mitochondrial regulatory function.\",\n      \"method\": \"CASP9 knockout (CRISPR), ectopic re-expression rescue, pharmacological inhibition, super-resolution microscopy, western blot for ATG3 and LC3 lipidation, mitochondrial membrane potential assay\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined molecular phenotype, rescue experiments, multiple orthogonal readouts in single rigorous study\",\n      \"pmids\": [\"31818185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CASP9 localizes to endosomal membranes and facilitates retrograde transport of IGF2R/CI-MPR from endosomes to the trans-Golgi network via a non-apoptotic, non-catalytic mechanism. CASP9-deficient cells show missorted CTSD and other acid hydrolases, late endosome accumulation, and reduced lysosomal protein degradation. Rescue by a non-catalytic CASP9 mutant confirms the effect is independent of proteolytic activity. CASP9 interacts with retromer components VPS35, SNX1-SNX5 and SNX2-SNX6 dimers, as well as HGS/HRS/ESCRT-0 and clathrin heavy chain (CLTC).\",\n      \"method\": \"CASP9 KO and knockdown, co-immunoprecipitation of endosomal transport complexes, rescue with non-catalytic mutant, subcellular fractionation, immunofluorescence, IGF2R degradation assay\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO with defined molecular phenotype, catalytic mutant rescue, reciprocal Co-IP identifying binding partners, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"32397873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In KRAS-mutant NSCLC cells surviving HSP90 inhibition, elevated CASP9 prodomain expression at late endosomal/pre-lysosomal membranes serves as a cell survival mechanism that does not involve CASP9 apoptotic activity and is largely ATG7-independent.\",\n      \"method\": \"HSP90 inhibitor treatment, CASP9 expression analysis, subcellular localization by immunofluorescence, functional cell survival assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, localization linked to functional consequence, but mechanistic details limited in abstract\",\n      \"pmids\": [\"29561705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NTD-specific missense variant p.Y251C in CASP9 attenuates apoptosis by reducing CASP9 protein expression and decreasing intrinsic apoptosis pathway activity (loss-of-function). A recurrent p.R191G variant does not affect intrinsic apoptosis under normal conditions but completely inhibits apoptosis induced by low folic acid medium, demonstrating gene-environment interaction.\",\n      \"method\": \"High-throughput sequencing of NTD cases and controls, functional apoptosis assays in transiently transfected neuroepithelial cells and HEK293T cells, caspase activity assays under complete and low-FA conditions\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mutagenesis in cell-based assays with defined apoptotic readouts, single lab with two orthogonal methods\",\n      \"pmids\": [\"29365368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NF-κB directly binds to the CASP9 promoter and upregulates CASP9 expression in TNFα-treated HeLa and HepG2 cells. NF-κB simultaneously downregulates miR-1276, which itself represses CASP9, forming a coherent feed-forward loop that amplifies CASP9 upregulation. CASP9 is subsequently activated and mediates TNFα-promoted apoptosis induced by doxorubicin; a CASP9 activation inhibitor significantly represses this pro-apoptotic effect.\",\n      \"method\": \"ChIP (NF-κB binding to CASP9 and miR-1276 promoters), luciferase reporter, western blot for CASP9 activation, pharmacological inhibition of CASP9\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays plus functional inhibition, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32225068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CASP9-deficient MEFs (casp9-/-) show prolonged activation of the unfolded protein response (UPR) and autophagy compared to casp9+/+ MEFs under ER stress, which display only transient UPR/autophagy activation. Casp9-/- MEFs are resistant to ER stress-induced cell death, but prolonged exposure leads to activation of a non-canonical, caspase-mediated mode of cell death.\",\n      \"method\": \"Comparative analysis of casp9+/+ vs casp9-/- mouse embryonic fibroblasts under ER stress, UPR markers, autophagy markers, cell viability assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic KO MEF comparison with multiple pathway readouts, single lab\",\n      \"pmids\": [\"25086361\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CASP9 (caspase-9) is an initiator caspase that is activated by granzyme B cleavage at Asp330 (or by CPP32/caspase-3 in a downstream cascade) to become an active cysteine protease that cleaves PARP and propagates the intrinsic apoptotic cascade; it is recruited into the apoptosome with APAF-1 and cytochrome c (positively regulated by histone H1.2 upon DNA damage), is transcriptionally upregulated by NF-κB via a miR-1276 feed-forward loop; and beyond apoptosis, CASP9 performs non-apoptotic functions including maintenance of mitochondrial homeostasis required for autophagosome maturation/closure via the Atg8 conjugation system, and non-catalytic facilitation of IGF2R retrograde endosome-to-TGN transport through interactions with retromer (VPS35) and SNX-BAR complexes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CASP9 (caspase-9) is an initiator cysteine protease of the intrinsic apoptotic pathway that, once proteolytically activated, cleaves downstream death substrates including poly(ADP-ribose) polymerase (PARP) [#0]. It is processed and activated by the cytotoxic lymphocyte protease granzyme B and operates within a protease cascade in which mature caspase-3/CPP32 cleaves pro-CASP9 preferentially at Asp330 to liberate its catalytic subunits, placing CASP9 downstream of caspase-3 in granzyme B-mediated death [#0, #1]. Apoptosome-dependent activation of CASP9 requires assembly with APAF-1 and cytochrome c, a step positively regulated by histone H1.2 following UV-induced DNA damage [#2]. CASP9 expression is transcriptionally amplified by NF-\\u03baB, which directly binds the CASP9 promoter while repressing the CASP9-targeting miR-1276 in a coherent feed-forward loop that potentiates TNF\\u03b1/doxorubicin-induced apoptosis [#7]. Beyond apoptosis, CASP9 has distinct non-apoptotic roles: it maintains mitochondrial homeostasis and is required for autophagosome membrane sealing and maturation through proper ATG3 function and Atg8-family (GABARAPL1) lipidation [#3], and it acts non-catalytically at endosomal membranes to facilitate retrograde IGF2R/CI-MPR transport from endosomes to the trans-Golgi network via interactions with the retromer subunit VPS35, SNX-BAR dimers (SNX1-SNX5, SNX2-SNX6), ESCRT-0 (HGS), and clathrin heavy chain [#4]. Loss-of-function CASP9 variants that attenuate intrinsic apoptosis are associated with neural tube defects, including a folate-dependent gene-environment interaction [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established CASP9 as a death protease by showing it is activated by granzyme B and cleaves a canonical apoptotic substrate, defining its place in cytotoxic-lymphocyte-triggered apoptosis.\",\n      \"evidence\": \"In vitro granzyme B cleavage assay, overexpression in MCF7 cells, and PARP cleavage readout\",\n      \"pmids\": [\"8663294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Did not resolve the physiological upstream activator versus granzyme B\",\n        \"Apoptosome requirement for activation not yet defined\",\n        \"No structural basis for the divergent QACGG active site\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined the precise activating cleavage site (Asp330) and ordered the cascade, placing CASP9 downstream of caspase-3/CPP32 in granzyme B-mediated apoptosis.\",\n      \"evidence\": \"In vitro cleavage with site-directed Asp330 mutagenesis and SDS-PAGE analysis of subunit products\",\n      \"pmids\": [\"8900201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Hierarchy between CASP9 and caspase-3 in other death stimuli not addressed\",\n        \"In-cell relevance of each cleavage site not quantified\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified a DNA-damage-linked positive regulator of apoptosome activation, showing histone H1.2 promotes APAF-1/CASP9/cytochrome c assembly and downstream caspase-3/7 activation.\",\n      \"evidence\": \"Affinity labeling, mass spectrometry, and cell-free caspase activation assay after UV irradiation\",\n      \"pmids\": [\"17618626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Stoichiometry and direct binding interface within the apoptosome unstructured\",\n        \"In vivo contribution of H1.2 to apoptosis not established\",\n        \"Single-lab finding without independent replication in the corpus\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed a function for CASP9 in restraining ER-stress responses, where its loss prolongs UPR and autophagy and confers resistance to ER-stress-induced death.\",\n      \"evidence\": \"Comparison of isogenic casp9+/+ and casp9-/- MEFs under ER stress with UPR, autophagy, and viability readouts\",\n      \"pmids\": [\"25086361\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular mechanism linking CASP9 to UPR resolution unknown\",\n        \"Whether catalytic activity is required not tested\",\n        \"Nature of the non-canonical death mode undefined\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Connected CASP9 to human disease by showing loss-of-function variants attenuate intrinsic apoptosis, including a folate-dependent gene-environment interaction relevant to neural tube defects.\",\n      \"evidence\": \"Sequencing of NTD cohorts plus functional apoptosis/caspase assays in neuroepithelial and HEK293T cells under complete and low-folate conditions\",\n      \"pmids\": [\"29365368\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Causality in NTD pathogenesis not established beyond cell-based assays\",\n        \"Mechanism of the R191G folate-conditional effect unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed a pro-survival, non-apoptotic role for the CASP9 prodomain at late endosomal/pre-lysosomal membranes in drug-tolerant KRAS-mutant cancer cells.\",\n      \"evidence\": \"HSP90 inhibitor treatment, prodomain expression analysis, immunofluorescence localization, and cell survival assays\",\n      \"pmids\": [\"29561705\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanistic basis of prodomain-driven survival not defined\",\n        \"ATG7-independence only partially characterized\",\n        \"Limited mechanistic detail available\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a non-apoptotic requirement for CASP9 in autophagosome maturation and mitochondrial homeostasis, separating its role in membrane sealing/ATG3-Atg8 lipidation from its mitochondrial regulatory function.\",\n      \"evidence\": \"CRISPR knockout with re-expression rescue, super-resolution microscopy, ATG3/LC3 lipidation blots, and mitochondrial membrane potential assays with H2O2 rescue\",\n      \"pmids\": [\"31818185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the maturation role requires catalytic activity not fully resolved here\",\n        \"Direct molecular target of CASP9 in ATG3 activation unidentified\",\n        \"Mechanism coupling mitochondrial ROS to ATG3 stability unclear\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined a catalytically independent scaffolding role for CASP9 in endosome-to-TGN retrograde transport, with rescue by a non-catalytic mutant confirming proteolysis-independent function.\",\n      \"evidence\": \"CASP9 KO/knockdown, reciprocal co-immunoprecipitation of retromer/SNX-BAR/ESCRT-0/clathrin partners, non-catalytic mutant rescue, fractionation, and IGF2R degradation assays\",\n      \"pmids\": [\"32397873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct versus indirect nature of each partner interaction not fully dissected\",\n        \"Structural basis of endosomal membrane recruitment unknown\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mapped transcriptional control of CASP9 by showing NF-\\u03baB directly activates the promoter while repressing miR-1276 in a feed-forward loop that amplifies CASP9-dependent apoptosis.\",\n      \"evidence\": \"ChIP and luciferase reporter assays plus CASP9 activation blots and pharmacological CASP9 inhibition in TNF\\u03b1/doxorubicin-treated HeLa and HepG2 cells\",\n      \"pmids\": [\"32225068\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Generality of the loop across cell types/stimuli untested\",\n        \"Quantitative contribution of miR-1276 versus direct activation unresolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CASP9 switches between its catalytic apoptotic role and its non-catalytic membrane-trafficking and autophagy functions, and what governs its differential localization, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model distinguishing apoptotic versus scaffolding conformations\",\n        \"Signals directing CASP9 to endosomal versus mitochondrial/apoptosome pools unknown\",\n        \"Direct molecular substrates/effectors in autophagy maturation unidentified\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 2, 7]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"apoptosome (APAF-1/cytochrome c/CASP9)\"\n    ],\n    \"partners\": [\n      \"APAF1\",\n      \"CYCS\",\n      \"HIST1H1C\",\n      \"VPS35\",\n      \"SNX1\",\n      \"SNX5\",\n      \"HGS\",\n      \"CLTC\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}